Union Investment and Investa have acquired the technology and pharmaceutical hub Campus Konstanz, which comprises twelve individual buildings. The area is part of the former premises of Altana Pharma AG and its subsidiary Byk Gulden. The acquisition took the form of an off-market transaction. GSK Stockmann advised on the legal aspects of the deal.
The technology and pharmaceutical hub Campus Konstanz is another acquisition for the special fund Urban Campus Nr. 1 launched by Union Investment and Investa Capital Management. At the beginning of this week, the partners had already announced the acquisition of the 27,000 m2 campus property ‘Loftwerk’ in Nuremberg for the same fund.
“Urban Campus Nr. 1 focuses primarily on campus properties, many of which have a certain history”, says Wolfgang Kessler, Managing Director of Union Investment Institutional Property GmbH. “Campus Konstanz has such a history and is an addition to the technology and pharmaceutical class of the fund’s portfolio.”
The twelve buildings in the technology and pharmaceutical hub Campus Konstanz were built between 1973 and 2008 and have been modernised numerous times in places. The mixture of office, laboratory, production and logistics areas on the campus lends the properties their typical campus character. The buildings feature 328 parking spaces and include a high bay warehouse and a small distribution centre. The largest tenants include the chemical and pharmaceutical company Takeda which occupies an area of 9,700 m2, a tax office of the state of Baden-Wuerttemberg with 5,400 m2, Siemens Postal, Parcel & Airport Logistics GmbH with 3,800 m2 and the pharmaceutical company Phast Development with 3,750 m2.
As with all of the properties in Urban Campus Nr. 1, Investa Asset Management GmbH is responsible for portfolio and tenant management on site as the campus manager. The general strategy of the fund – to develop the properties strategically through active campus management – is being implemented once again.
“By acquiring the campus property in Konstanz, we can continue to round off the profile of the fund Urban Campus Nr. 1 and add meaningful, sustainable usage concepts in the fields of technology and pharmaceuticals to its portfolio”, says Rainer Thaler, Managing Director of Investa Capital Management.